Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Direct observations: clinical cases, poisoning incidents and other

Administrative data

Endpoint:
direct observations: clinical cases, poisoning incidents and other
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Case report

Data source

Reference
Reference Type:
publication
Title:
Photodermatitis from anthraquinone
Author:
Menezes F and Valente A
Year:
1988
Bibliographic source:
Contact Dermatitis, 18, 171-172

Materials and methods

Study type:
clinical case study
Endpoint addressed:
other: photodermatitis
Principles of method if other than guideline:
A 40-year-old man, working in the paper pulp industry was seen with sub-acute dermatitis in exposed areas - face, neck, and dorsum of the hands. He was patch tested with standard series, anthraquinone from 2 manufacturers (10% pet.), vegetable allergens and oleoresins. Photopatch tests with a photoallergen tray, the 2 anthraquinones (10%) and Disperse blue 35 (1% pet.) were irradiated with UVA, UVB and visible light.

Test material

Constituent 1
Chemical structure
Reference substance name:
Anthraquinone
EC Number:
201-549-0
EC Name:
Anthraquinone
Cas Number:
84-65-1
Molecular formula:
C14H8O2
IUPAC Name:
9,10-dihydroanthracene-9,10-dione

Method

Type of population:
occupational
Subjects:
A 40-year-old man, working in the paper pulp industry was seen with sub-acute dermatitis in exposed areas - face, neck, and dorsum of the hands. He reported that the beginning of the dermatitis had almost coincided with the introduction of a new anthraquinone to the industrial process. For the next few months, he stayed away from the section, but any time that he re-entered the area, the dermatitis reappeared, with marked aggravation after sun exposure.
Route of exposure:
dermal
Reason of exposure:
intentional, occupational

Results and discussion

Effectivity of medical treatment:
The patient was changed to another department and the dermatitis cleared completely.

Any other information on results incl. tables

The patient was patch tested with standard series, anthraquinone from 2 manufacturers (10% pet.), vegetable allergens and oleoresins, and all were negative. Photopatch tests with a photoallergen tray, the 2 anthraquinones (10%) and Disperse blue 35 (1% pet.) were irradiated with UVA, UVB and visible light; the only positive (++) reaction was when anthraquinone was irradiated with UVA. A biopsy taken of the positive reaction showed eczema.

Determination of MED to UVA and UVB was normal. Photopatch tests with anthraquinone were performed in 5 controls and were negative. The patient was changed to another department and the dermatitis cleared completely.

Applicant's summary and conclusion

Conclusions:
The only positive (++) reaction was when anthraquinone was irradiated with UVA. A biopsy taken of the positive reaction showed eczema. The patient was changed to another department and the dermatitis cleared completely.
Executive summary:

A 40-year-old man, working in the paper pulp industry was seen with sub-acute dermatitis in exposed areas - face, neck, and dorsum of the hands. The patient was patch tested with standard series, anthraquinone from 2 manufacturers (10% pet.), vegetable allergens and oleoresins, and all were negative. Photopatch tests with a photoallergen tray, the 2 anthraquinones (10%) and Disperse blue 35 (1% pet.) were irradiated with UVA, UVB and visible light; the only positive (++) reaction was when anthraquinone was irradiated with UVA. A biopsy taken of the positive reaction showed eczema. Determination of MED to UVA and UVB was normal. Photopatch tests with anthraquinone were performed in 5 controls and were negative. The patient was changed to another department and the dermatitis cleared completely.